Rheumatoid Arthritis

Severe Obesity Linked to Rapid Progression of Disability in Rheumatoid Arthritis

Severe Obesity Linked to Rapid Progression of Disability in Rheumatoid Arthritis

By

Severe obesity is associated with more rapid progression of disability in rheumatoid arthritis.

Late-Life Mobility Limitations Linked to Obesity After Arthroplasty for OA in Women

Late-Life Mobility Limitations Linked to Obesity After Arthroplasty for OA in Women

By

Baseline obesity is associated with an increased risk for late-life mobility limitations in women undergoing joint replacement for OA.

Severe Obesity Tied to Faster Progression to Disability With Rheumatoid Arthritis

Severe Obesity Tied to Faster Progression to Disability With Rheumatoid Arthritis

Severely obese rheumatoid arthritis patients also had worse disability at baseline than overweight patients.

Rheumatoid Arthritis Not as Likely to Increase CVD Risk as Diabetes

Rheumatoid Arthritis Not as Likely to Increase CVD Risk as Diabetes

Using both public and private health insurance claims data, investigators conducted a retrospective cohort study to assess cardiovascular risk in the setting of diabetes and rheumatoid arthritis.

Abatacept May Improve Femoral Neck Bone Mineral Density in Rheumatoid Arthritis

Abatacept May Improve Femoral Neck Bone Mineral Density in Rheumatoid Arthritis

By

Abatacept was superior at increasing bone mineral density in the femoral neck compared with other biologic disease-modifying antirheumatic drugs, and may offer good efficacy for improving BMD in rheumatoid arthritis.

Reducing CV Risk in Patients With Rheumatoid Arthritis and Diabetes

Reducing CV Risk in Patients With Rheumatoid Arthritis and Diabetes

By

Abatacept conferred a greater reduction in cardiovascular risk compared with tumor necrosis factor inhibitors in patients with rheumatoid arthritis and diabetes.

Sign Up for Free e-Newsletters



CME Focus